S&P 500   3,346.81 (+0.57%)
DOW   27,361.97 (+0.59%)
QQQ   274.97 (+1.45%)
AAPL   456.57 (+3.71%)
MSFT   216.04 (+1.46%)
FB   266.15 (+6.84%)
GOOGL   1,505.40 (+1.78%)
AMZN   3,237.00 (+1.00%)
NVDA   454.00 (+0.56%)
CGC   17.71 (-7.81%)
BABA   264.20 (-0.27%)
TSLA   1,503.38 (+1.24%)
MU   48.75 (-4.51%)
GE   6.38 (-0.31%)
AMD   86.73 (+1.66%)
T   29.83 (-0.07%)
F   6.98 (+0.29%)
ACB   10.28 (-4.01%)
GILD   68.97 (-0.04%)
NFLX   509.70 (+1.51%)
DIS   131.59 (+3.12%)
BAC   25.44 (+0.20%)
BA   172.23 (-1.18%)
S&P 500   3,346.81 (+0.57%)
DOW   27,361.97 (+0.59%)
QQQ   274.97 (+1.45%)
AAPL   456.57 (+3.71%)
MSFT   216.04 (+1.46%)
FB   266.15 (+6.84%)
GOOGL   1,505.40 (+1.78%)
AMZN   3,237.00 (+1.00%)
NVDA   454.00 (+0.56%)
CGC   17.71 (-7.81%)
BABA   264.20 (-0.27%)
TSLA   1,503.38 (+1.24%)
MU   48.75 (-4.51%)
GE   6.38 (-0.31%)
AMD   86.73 (+1.66%)
T   29.83 (-0.07%)
F   6.98 (+0.29%)
ACB   10.28 (-4.01%)
GILD   68.97 (-0.04%)
NFLX   509.70 (+1.51%)
DIS   131.59 (+3.12%)
BAC   25.44 (+0.20%)
BA   172.23 (-1.18%)
S&P 500   3,346.81 (+0.57%)
DOW   27,361.97 (+0.59%)
QQQ   274.97 (+1.45%)
AAPL   456.57 (+3.71%)
MSFT   216.04 (+1.46%)
FB   266.15 (+6.84%)
GOOGL   1,505.40 (+1.78%)
AMZN   3,237.00 (+1.00%)
NVDA   454.00 (+0.56%)
CGC   17.71 (-7.81%)
BABA   264.20 (-0.27%)
TSLA   1,503.38 (+1.24%)
MU   48.75 (-4.51%)
GE   6.38 (-0.31%)
AMD   86.73 (+1.66%)
T   29.83 (-0.07%)
F   6.98 (+0.29%)
ACB   10.28 (-4.01%)
GILD   68.97 (-0.04%)
NFLX   509.70 (+1.51%)
DIS   131.59 (+3.12%)
BAC   25.44 (+0.20%)
BA   172.23 (-1.18%)
S&P 500   3,346.81 (+0.57%)
DOW   27,361.97 (+0.59%)
QQQ   274.97 (+1.45%)
AAPL   456.57 (+3.71%)
MSFT   216.04 (+1.46%)
FB   266.15 (+6.84%)
GOOGL   1,505.40 (+1.78%)
AMZN   3,237.00 (+1.00%)
NVDA   454.00 (+0.56%)
CGC   17.71 (-7.81%)
BABA   264.20 (-0.27%)
TSLA   1,503.38 (+1.24%)
MU   48.75 (-4.51%)
GE   6.38 (-0.31%)
AMD   86.73 (+1.66%)
T   29.83 (-0.07%)
F   6.98 (+0.29%)
ACB   10.28 (-4.01%)
GILD   68.97 (-0.04%)
NFLX   509.70 (+1.51%)
DIS   131.59 (+3.12%)
BAC   25.44 (+0.20%)
BA   172.23 (-1.18%)
Log in

NASDAQ:NEPTNeptune Wellness Solutions Stock Price, Forecast & News

$2.93
-0.01 (-0.34 %)
(As of 08/6/2020 03:37 PM ET)
Add
Compare
Today's Range
$2.82
Now: $2.93
$2.94
50-Day Range
$2.55
MA: $2.89
$3.15
52-Week Range
$0.96
Now: $2.93
$5.24
Volume31,656 shs
Average Volume762,165 shs
Market Capitalization$323.74 million
P/E RatioN/A
Dividend YieldN/A
Beta2.65
Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$22.05 million
Book Value$1.09 per share

Profitability

Net Income$-45,760,000.00
Net Margins-204.83%

Miscellaneous

Employees58
Market Cap$323.74 million
Next Earnings Date8/11/2020 (Confirmed)
OptionableOptionable
$2.93
-0.01 (-0.34 %)
(As of 08/6/2020 03:37 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

How has Neptune Wellness Solutions' stock been impacted by COVID-19 (Coronavirus)?

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEPT shares have increased by 138.8% and is now trading at $2.89.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Neptune Wellness Solutions?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Neptune Wellness Solutions
.

When is Neptune Wellness Solutions' next earnings date?

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020.
View our earnings forecast for Neptune Wellness Solutions
.

How can I listen to Neptune Wellness Solutions' earnings call?

Neptune Wellness Solutions will be holding an earnings conference call on Tuesday, August 11th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) issued its earnings results on Wednesday, June, 10th. The biotechnology company reported ($0.21) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.13. The biotechnology company earned $7.11 million during the quarter, compared to the consensus estimate of $6.32 million. Neptune Wellness Solutions had a negative net margin of 204.83% and a negative return on equity of 51.03%.
View Neptune Wellness Solutions' earnings history
.

What guidance has Neptune Wellness Solutions issued on next quarter's earnings?

Neptune Wellness Solutions updated its first quarter 2021 After-Hours earnings guidance on Wednesday, June, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $18-22 million.

What price target have analysts set for NEPT?

2 equities research analysts have issued twelve-month target prices for Neptune Wellness Solutions' shares. Their forecasts range from $3.75 to $3.75. On average, they expect Neptune Wellness Solutions' share price to reach $3.75 in the next year. This suggests a possible upside of 29.8% from the stock's current price.
View analysts' price targets for Neptune Wellness Solutions
.

Has Neptune Wellness Solutions been receiving favorable news coverage?

Headlines about NEPT stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neptune Wellness Solutions earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Neptune Wellness Solutions
.

Who are some of Neptune Wellness Solutions' key competitors?

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Amarin (AMRN), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), Crispr Therapeutics (CRSP) and Sangamo Therapeutics (SGMO).

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the following people:
  • Mr. James S. Hamilton, Pres, CEO & Director
  • Mr. Mario Paradis, VP & CFO
  • Mr. Marc Vaugeois, VP of Sales
  • Mr. Michel Timperio, Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Who are Neptune Wellness Solutions' major shareholders?

Neptune Wellness Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include AdvisorShares Investments LLC (0.40%) and Hilton Capital Management LLC (0.07%).

Which institutional investors are buying Neptune Wellness Solutions stock?

NEPT stock was purchased by a variety of institutional investors in the last quarter, including Hilton Capital Management LLC, and AdvisorShares Investments LLC.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $2.89.

How big of a company is Neptune Wellness Solutions?

Neptune Wellness Solutions has a market capitalization of $319.32 million and generates $22.05 million in revenue each year. The biotechnology company earns $-45,760,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.